{
  "main_header": {
    "sid": 156274,
    "name": "Natco Pharma",
    "stock_name": "Natco Pharma",
    "full_name": "Natco Pharma Ltd.",
    "name_url": "stocks-analysis/natco-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "911.50",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "911.50",
    "mcapval": "16,326.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524816,
    "symbol": "NATCOPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE987B01026",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "2.34 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/natco-pharma-156274-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "NATCO Pharma rallies after USFDA grants tentative approval for Olaparib tablets",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-20 16:51:00",
        "description": "NATCO Pharma rallies after USFDA grants tentative approval for Olaparib tablets  Business Standard..."
      },
      {
        "title": "Natco Pharma raises Adcock Ingram stake to 49%, pays 1,060 crore",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-14 12:28:55",
        "description": "Natco Pharma raises Adcock Ingram stake to 49%, pays 1,060 crore  BusinessLine..."
      },
      {
        "title": "Natco Pharma raises Adcock Ingram stake to 49%, pays 1,060 crore",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-14 12:28:55",
        "description": "Natco Pharma raises Adcock Ingram stake to 49%, pays 1,060 crore  BusinessLine..."
      },
      {
        "title": "Natco Pharma shares gain 2.5% on 2,500 crore South Africa investment plan",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-09 10:52:03",
        "description": "Natco Pharma shares gain 2.5% on 2,500 crore South Africa investment plan  Business Standard..."
      },
      {
        "title": "Natco Pharma approves investment up to 1,400 crore in wholly-owned subsidiary in South Africa",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-08 14:38:51",
        "description": "Natco Pharma approves investment up to 1,400 crore in wholly-owned subsidiary in South Africa  BusinessLine..."
      }
    ],
    "total": 5,
    "sid": "156274",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/natco-pharma-156274"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Considering Un-Audited Financial Results For The Quarter Ended 30Th June 2026 And Declare Interim Dividend If Any",
      "datetime": "06-Aug-2026",
      "details": "Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Un-audited Financial Results for the quarter ended 30th June 2026 and declare Interim Dividend if any for the FY 2026-27",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "18-Jul-2026",
      "details": "Press Release: NATCO receives Tentative Approval for Olaparib Tablets from the United States Food and Drug Administration (U.S. FDA)",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "14-Jul-2026",
      "details": "Order passed by Assistant Commissioner (ST)(FAC) Tenali Circle Tenali Andhra Pradesh",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has declared <strong>75%</strong> dividend, ex-date: 18 Feb 26",
          "dt": "2026-02-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has announced <strong>2:10</strong> stock split, ex-date: 26 Nov 15",
          "dt": "2015-11-26",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

NATCO Pharma rallies after USFDA grants tentative approval for Olaparib tablets

2026-07-20 16:51:00

NATCO Pharma rallies after USFDA grants tentative approval for Olaparib tablets Business Standard...

Read More

Natco Pharma raises Adcock Ingram stake to 49%, pays 1,060 crore

2026-07-14 12:28:55

Natco Pharma raises Adcock Ingram stake to 49%, pays 1,060 crore BusinessLine...

Read More

Natco Pharma raises Adcock Ingram stake to 49%, pays 1,060 crore

2026-07-14 12:28:55

Natco Pharma raises Adcock Ingram stake to 49%, pays 1,060 crore BusinessLine...

Read More

Natco Pharma shares gain 2.5% on 2,500 crore South Africa investment plan

2026-07-09 10:52:03

Natco Pharma shares gain 2.5% on 2,500 crore South Africa investment plan Business Standard...

Read More

Natco Pharma approves investment up to 1,400 crore in wholly-owned subsidiary in South Africa

2026-07-08 14:38:51

Natco Pharma approves investment up to 1,400 crore in wholly-owned subsidiary in South Africa BusinessLine...

Read More

View All News